Lynne M. Laube's Insider Trades & SAST Disclosures
Lynne M. Laube's most recent trade in Nerdwallet Inc - Ordinary Shares - Class A was a trade of 11,061 Class A Common Stock done . Disclosure was reported to the exchange on May 14, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Lynne M. Laube.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nerdwallet Inc - Ordinary ... | Lynne M. Laube | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 11,061 | 41,996 | - | 0 | Class A Common Stock | |
| Nerdwallet Inc - Ordinary ... | Lynne M. Laube | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 15,120 | 30,935 | - | 0 | Class A Common Stock | |
| Cardlytics Inc | Lynne M. Laube | Director | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 08 Nov 2022 | 4 | 313,547 (1%) | 0% | 4 | 16 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director | Sale of securities on an exchange or to another person at price $ 4.32 per share. | 07 Nov 2022 | 6,430 | 313,903 (1%) | 0% | 4.3 | 27,778 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director | Sale of securities on an exchange or to another person at price $ 3.99 per share. | 07 Nov 2022 | 352 | 313,551 (1%) | 0% | 4.0 | 1,403 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2022 | 14,062 | 0 | - | - | Performance Stock Unit | |
| Cardlytics Inc | Lynne M. Laube | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2022 | 14,062 | 320,333 (1%) | 0% | 0 | Common Stock | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.19 per share. | 05 Aug 2022 | 6,612 | 306,271 (1%) | 0% | 15.2 | 100,436 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jun 2022 | 60,000 | 298,820 (1%) | 0% | 0 | Common Stock | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2022 | 14,063 | 14,062 | - | - | Performance Stock Unit | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2022 | 14,063 | 312,883 (1%) | 0% | 0 | Common Stock | |
| Nerdwallet Inc - Ordinary ... | Lynne M. Laube | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 15,815 | 15,815 | - | 0 | Class A Common Stock | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 33.60 per share. | 05 May 2022 | 17,973 | 358,530 (1%) | 0% | 33.6 | 603,893 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2022 | 14,063 | 14,062 | - | - | Performance Stock Unit | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2022 | 14,063 | 376,503 (1%) | 0% | 0 | Common Stock | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2022 | 6,622 | 362,440 (1%) | 0% | 0 | Common Stock | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2022 | 6,622 | 19,868 | - | - | Restricted Stock Unit | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 20,161 | 355,818 (1%) | 0% | 0 | Common Stock | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 20,161 | 40,322 | - | - | Restricted Stock Unit | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2022 | 63,233 | 63,293 | - | - | Restricted Stock Unit | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2022 | 2,766 | 335,657 (1%) | 0% | 0 | Common Stock | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Mar 2022 | 1,112 | 332,891 (1%) | 0% | 0 | Common Stock | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2021 | 56,250 | 56,250 | - | - | Performance Stock Unit | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2021 | 28,125 | 28,125 | - | - | Performance Stock Unit | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2021 | 28,125 | 351,593 (1%) | 0% | 0 | Common Stock | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 68.63 per share. | 09 Dec 2021 | 7,432 | 339,617 (1%) | 0% | 68.6 | 510,058 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 67.62 per share. | 09 Dec 2021 | 4,544 | 347,049 (1%) | 0% | 67.6 | 307,265 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 69.36 per share. | 09 Dec 2021 | 1,100 | 338,517 (1%) | 0% | 69.4 | 76,296 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 90.23 per share. | 05 Nov 2021 | 10,676 | 325,781 (1%) | 0% | 90.2 | 963,295 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 92.95 per share. | 05 Nov 2021 | 911 | 323,467 (1%) | 0% | 92.9 | 84,677 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 92.26 per share. | 05 Nov 2021 | 800 | 324,378 (1%) | 0% | 92.3 | 73,808 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 90.88 per share. | 05 Nov 2021 | 603 | 325,178 (1%) | 0% | 90.9 | 54,801 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2021 | 56,250 | 56,250 | - | - | Performance Stock Unit | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2021 | 28,125 | 28,125 | - | - | Performance Stock Unit | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2021 | 28,125 | 336,457 (1%) | 0% | - | Common Stock | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Sep 2021 | 4,000 | 334,003 (1%) | 0% | 0 | Common Stock | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Sep 2021 | 514 | 338,003 (1%) | 0% | 0 | Common Stock | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2021 | 3,376 | 44,025 | - | - | Employee Stock Option (Right to Buy) | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.00 per share. | 14 Jul 2021 | 3,376 | 311,708 (1%) | 0% | 20 | 67,520 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.00 per share. | 14 Jul 2021 | 2,138 | 310,470 (1%) | 0% | 20 | 42,760 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2021 | 2,138 | 41,887 | - | - | Employee Stock Option (Right to Buy) | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 123.77 per share. | 14 Jul 2021 | 1,976 | 309,732 (1%) | 0% | 123.8 | 244,570 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 124.56 per share. | 14 Jul 2021 | 1,100 | 308,632 (1%) | 0% | 124.6 | 137,016 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 124.95 per share. | 14 Jul 2021 | 700 | 308,432 (1%) | 0% | 125.0 | 87,465 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 123.03 per share. | 14 Jul 2021 | 638 | 309,132 (1%) | 0% | 123.0 | 78,493 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 122.29 per share. | 14 Jul 2021 | 400 | 309,770 (1%) | 0% | 122.3 | 48,916 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 120.42 per share. | 14 Jul 2021 | 300 | 310,170 (1%) | 0% | 120.4 | 36,126 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 125.77 per share. | 14 Jul 2021 | 300 | 308,332 (1%) | 0% | 125.8 | 37,731 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 125.56 per share. | 14 Jul 2021 | 100 | 308,332 (1%) | 0% | 125.6 | 12,556 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2021 | 5,424 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.32 per share. | 03 Jun 2021 | 5,424 | 313,756 (1%) | 0% | 8.3 | 45,128 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 101.52 per share. | 03 Jun 2021 | 4,775 | 309,971 (1%) | 0% | 101.5 | 484,758 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 102.65 per share. | 03 Jun 2021 | 1,539 | 308,432 (1%) | 0% | 102.6 | 157,978 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2021 | 990 | 48,301 | - | - | Employee Stock Option (Right to Buy) | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.00 per share. | 03 Jun 2021 | 990 | 314,746 (1%) | 0% | 20 | 19,800 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2021 | 900 | 47,401 | - | - | Employee Stock Option (Right to Buy) | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 100.67 per share. | 03 Jun 2021 | 900 | 308,332 (1%) | 0% | 100.7 | 90,603 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.00 per share. | 03 Jun 2021 | 900 | 309,232 (1%) | 0% | 20 | 18,000 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 103.16 per share. | 03 Jun 2021 | 100 | 308,332 (1%) | 0% | 103.2 | 10,316 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 102.33 per share. | 07 May 2021 | 2,900 | 310,514 (1%) | 0% | 102.3 | 296,757 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 101.08 per share. | 07 May 2021 | 2,300 | 313,414 (1%) | 0% | 101.1 | 232,484 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 103.48 per share. | 07 May 2021 | 1,900 | 308,614 (1%) | 0% | 103.5 | 196,612 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 100.24 per share. | 07 May 2021 | 1,453 | 315,714 (1%) | 0% | 100.2 | 145,649 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 104.36 per share. | 07 May 2021 | 500 | 308,114 (1%) | 0% | 104.4 | 52,180 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.32 per share. | 12 Apr 2021 | 2,139 | 319,306 (1%) | 0% | 8.3 | 17,796 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.32 per share. | 12 Apr 2021 | 2,139 | 319,306 (1%) | 0% | 8.3 | 17,796 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2021 | 2,139 | 5,424 | - | - | Employee Stock Option (Right to Buy) | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2021 | 2,139 | 7,563 | - | - | Employee Stock Option (Right to Buy) | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 111.31 per share. | 12 Apr 2021 | 997 | 317,408 (1%) | 0% | 111.3 | 110,976 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 104.95 per share. | 12 Apr 2021 | 900 | 317,882 (1%) | 0% | 105.0 | 94,455 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 109.83 per share. | 12 Apr 2021 | 700 | 318,405 (1%) | 0% | 109.8 | 76,881 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 105.75 per share. | 12 Apr 2021 | 315 | 317,567 (1%) | 0% | 105.7 | 33,311 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 104.07 per share. | 12 Apr 2021 | 300 | 318,782 (1%) | 0% | 104.1 | 31,221 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 111.90 per share. | 12 Apr 2021 | 241 | 317,167 (1%) | 0% | 111.9 | 26,968 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 102.88 per share. | 12 Apr 2021 | 224 | 319,082 (1%) | 0% | 102.9 | 23,045 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 108.15 per share. | 12 Apr 2021 | 201 | 319,105 (1%) | 0% | 108.1 | 21,738 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 107.78 per share. | 12 Apr 2021 | 200 | 317,367 (1%) | 0% | 107.8 | 21,556 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 110.88 per share. | 12 Apr 2021 | 100 | 317,167 (1%) | 0% | 110.9 | 11,088 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 108.64 per share. | 12 Apr 2021 | 100 | 317,267 (1%) | 0% | 108.6 | 10,864 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2021 | 26,490 | 26,490 | - | - | Restricted Stock Unit | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2021 | 20,161 | 60,484 | - | - | Restricted Stock Unit | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2021 | 20,161 | 317,167 (1%) | 0% | 0 | Common Stock | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.32 per share. | 23 Mar 2021 | 2,139 | 299,145 (1%) | 0% | 8.3 | 17,796 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.32 per share. | 23 Mar 2021 | 2,139 | 299,145 (1%) | 0% | 8.3 | 17,796 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Mar 2021 | 2,139 | 11,841 | - | - | Employee Stock Option (Right to Buy) | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Mar 2021 | 2,139 | 9,702 | - | - | Employee Stock Option (Right to Buy) | |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 123.63 per share. | 23 Mar 2021 | 629 | 298,516 (1%) | 0% | 123.6 | 77,763 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 128.99 per share. | 23 Mar 2021 | 610 | 297,106 (1%) | 0% | 129.0 | 78,684 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 118.33 per share. | 23 Mar 2021 | 601 | 297,806 (1%) | 0% | 118.3 | 71,116 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 116.04 per share. | 23 Mar 2021 | 538 | 298,607 (1%) | 0% | 116.0 | 62,430 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 126.66 per share. | 23 Mar 2021 | 500 | 297,716 (1%) | 0% | 126.7 | 63,330 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 120.97 per share. | 23 Mar 2021 | 300 | 297,206 (1%) | 0% | 121.0 | 36,291 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 119.69 per share. | 23 Mar 2021 | 300 | 297,506 (1%) | 0% | 119.7 | 35,907 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 125.15 per share. | 23 Mar 2021 | 300 | 298,216 (1%) | 0% | 125.2 | 37,545 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 117.06 per share. | 23 Mar 2021 | 200 | 298,407 (1%) | 0% | 117.1 | 23,412 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 129.70 per share. | 23 Mar 2021 | 100 | 297,006 (1%) | 0% | 129.7 | 12,970 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 122.77 per share. | 23 Mar 2021 | 100 | 297,106 (1%) | 0% | 122.8 | 12,277 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 124.00 per share. | 23 Mar 2021 | 100 | 297,006 (1%) | 0% | 124 | 12,400 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.32 per share. | 10 Feb 2021 | 2,139 | 299,145 (1%) | 0% | 8.3 | 17,796 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.32 per share. | 10 Feb 2021 | 2,139 | 299,145 (1%) | 0% | 8.3 | 17,796 | Common Stock |
| Cardlytics Inc | Lynne M. Laube | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2021 | 2,139 | 13,980 | - | - | Employee Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges